The IMMY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the IMMY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The IMMY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View IMMY Detailed Price Forecast - CNN Money||View IMMY Detailed Summary - Google Finance|
|View IMMY Detailed Summary - Yahoo! Finance||View IMMY Stock Research & Analysis - Zacks.com|
|View IMMY Trends & Analysis - Trade-Ideas||View IMMY Major Holders - Barrons|
|View IMMY Call Transcripts - NASDAQ||View IMMY Breaking News & Analysis - Seeking Alpha|
|View IMMY Annual Report - CompanySpotlight.com||View IMMY OTC Short Report - OTCShortReport.com|
|View IMMY Fundamentals - TradeKing||View IMMY SEC Filings - Bar Chart|
|View Historical Prices for IMMY - The WSJ||View Performance/Total Return for IMMY - Morningstar|
|View the Analyst Estimates for IMMY - MarketWatch||View the Earnings History for IMMY - CNBC|
|View the IMMY Earnings - StockMarketWatch||View IMMY Buy or Sell Recommendations - MacroAxis|
|View the IMMY Bullish Patterns - American Bulls||View IMMY Short Pain Metrics - ShortPainBot.com|
|View IMMY Stock Mentions - StockTwits||View IMMY Stock Mentions - PennyStockTweets|
|View IMMY Stock Mentions - Twitter||View IMMY Investment Forum News - Investor Hub|
|View IMMY Stock Mentions - Yahoo! Message Board||View IMMY Stock Mentions - Seeking Alpha|
|View Insider Transactions for IMMY - SECform4.com||View Insider Transactions for IMMY - Insider Cow|
|View IMMY Major Holdings Summary - CNBC||View Insider Disclosure for IMMY - OTC Markets|
|View Insider Transactions for IMMY - Yahoo! Finance||View Institutional Holdings for IMMY - NASDAQ|
|View IMMY Stock Insight & Charts - FinViz.com||View IMMY Investment Charts - StockCharts.com|
|View IMMY Stock Overview & Charts - BarChart||View IMMY User Generated Charts - Trading View|
Imprimis Pharmaceuticals to Host its Fourth Quarter 2017 Financial Report Conference Call and Webcast on March 8, 2018 at 4:30 p.m. EST
Posted on Thursday February 15, 2018
SAN DIEGO, Feb. 15, 2018 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (IMMY), an ophthalmology-focused pharmaceutical company, today announced it will release fourth quarter 2017 financial results after the close of trading on Thursday, March 8, 2018. The company will host a conference call at 4:30 p.m. EST/1:30 p.m. PST on the same day to discuss the financial results and recent business developments. To participate in the call, please dial (877) 407-8035 for domestic callers or (201) 689-8035 for international callers. To listen to the webcast, please click here or visit the investor relations section of the Imprimis website at www.ImprimisRx.com. A dial in replay of the call will be available until April 8, 2018. To access the replay, dial (877) 481-4010 domestically or (919) 882-2331 internationally and reference Replay ID: 25720. The webcast replay will be available until June 8, 2018.
Today’s Research Reports on Trending Tickers: Corbus Pharmaceuticals and Imprimis Pharmaceuticals
Posted on Wednesday January 31, 2018
NEW YORK, NY / ACCESSWIRE / January 31, 2018 / U.S. markets fell sharply Tuesday for the second consecutive day. Both the Dow Jones and S&P 500 experienced their largest one day drop of 2018. The Dow Jones ...
Who Owns Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)?
Posted on Tuesday January 30, 2018
I am going to take a deep dive into Imprimis Pharmaceuticals Inc’s (NASDAQ:IMMY) most recent ownership structure, not a frequent subject of discussion among individual investors. Ownership structure has beenRead More...
Imprimis Pharmaceuticals Now Making Available Two Glaucoma Drugs on FDA's Drug Shortage List
Posted on Tuesday January 30, 2018
SAN DIEGO, Jan. 30, 2018 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (IMMY), an ophthalmology-focused pharmaceutical company, today announced that it is now dispensing preservative-free dorzolamide and a preservative-free dorzolamide/timolol formulation after dorzolamide and the commercial products, Cosopt® and Cosopt® PF, were added to the FDA Drug Shortage List.